4 ms·

From the full text: > It has recently been reported that the incidence of myocarditis and pericarditis is increased in COVID-19 patients during the acute illne

From the full text: > It has recently been reported that the incidence of myocarditis and pericarditis is increased in COVID-19 patients during the acute illness [12]. However; whether or not myocarditis and pericarditis after the recovery period are a part of the long COVID-19 syndrome is yet unknown. Herein, we studied the incidence of myocarditis and pericarditis in a large cohort of COVID-19 patients after recovering from the acute infection. It's looking at myocarditis and pericarditis not in the acute phase, but post. And iirc there has been other papers showing there is an increased risk in a 12 month followup.

baxtr 4y ago
You did not include the most relevant part of the paper's abstract: > We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.
- someNameIG 4y ago
  I was more just pointing out that this was in the recovery phase, not during the acute infection. I've seen people use this paper as evidence that a covid infection does not increase the risk of CV incidents. And this seems to be an outlier anyway: > In conclusion, either symptomatic or asymptomatic SARS-CoV-2 infection is associated with an increased risk for late CV outcomes and has a causal effect on all-cause mortality in a late post-COVID-19 period. https://www.ajconline.org/article/S0002-9149(22)00655-5/fulltext https://www.ajconline.org/article/S0002-9149(22)00655-5/full... > In summary, using a national cohort of people with COVID-19, we show that risk and 12-month burden of incident cardiovascular disease are substantial and span several cardiovascular disease categories (ischemic and non-ischemic heart disease, dysrhythmias and others). The risks and burdens of cardiovascular disease were evident even among those whose acute COVID-19 did not necessitate hospitalization. https://www.nature.com/articles/s41591-022-01689-3 https://www.nature.com/articles/s41591-022-01689-3 > The 12-month risk of incidental cardiovascular diseases is substantially higher in the COVID-19 survivors than the non-COVID-19 controls. Clinicians and patients with a history of COVID-19 should pay attention to their cardiovascular health in long term. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00349-2/fulltext https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...
  - rgrieselhuber 4y ago
    > First, we censored cohort participants at the time of receiving the first dose of any COVID-19 vaccine. Second, we adjusted for vaccination as a time-varying covariate. What does this mean, specifically?

baxtr 4y ago

You did not include the most relevant part of the paper's abstract: > We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.

someNameIG 4y ago
I was more just pointing out that this was in the recovery phase, not during the acute infection. I've seen people use this paper as evidence that a covid infection does not increase the risk of CV incidents. And this seems to be an outlier anyway: > In conclusion, either symptomatic or asymptomatic SARS-CoV-2 infection is associated with an increased risk for late CV outcomes and has a causal effect on all-cause mortality in a late post-COVID-19 period. https://www.ajconline.org/article/S0002-9149(22)00655-5/fulltext https://www.ajconline.org/article/S0002-9149(22)00655-5/full... > In summary, using a national cohort of people with COVID-19, we show that risk and 12-month burden of incident cardiovascular disease are substantial and span several cardiovascular disease categories (ischemic and non-ischemic heart disease, dysrhythmias and others). The risks and burdens of cardiovascular disease were evident even among those whose acute COVID-19 did not necessitate hospitalization. https://www.nature.com/articles/s41591-022-01689-3 https://www.nature.com/articles/s41591-022-01689-3 > The 12-month risk of incidental cardiovascular diseases is substantially higher in the COVID-19 survivors than the non-COVID-19 controls. Clinicians and patients with a history of COVID-19 should pay attention to their cardiovascular health in long term. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00349-2/fulltext https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...
- rgrieselhuber 4y ago
  > First, we censored cohort participants at the time of receiving the first dose of any COVID-19 vaccine. Second, we adjusted for vaccination as a time-varying covariate. What does this mean, specifically?